Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Bioengineers look beyond patents.

Ledford H.

Nature. 2013 Jul 4;499(7456):16-7. doi: 10.1038/499016a. No abstract available.

PMID:
23823774
2.

Synthetic biology: Cultural divide.

Nelson B.

Nature. 2014 May 8;509(7499):152-4. doi: 10.1038/509152a. No abstract available.

PMID:
24805328
3.

Napster case spills into biotech sector.

Bouchie A.

Nat Biotechnol. 2004 Sep;22(9):1185-6. No abstract available.

PMID:
15384189
4.

Sharing information is preferable to patenting.

Macilwain C.

Nature. 2013 Jun 20;498(7454):273. doi: 10.1038/498273a. No abstract available.

PMID:
23783592
5.

Synthetic biology: Beyond divisions.

[No authors listed]

Nature. 2014 May 8;509(7499):151. doi: 10.1038/509151a. No abstract available.

PMID:
24805327
6.

Open source synthetic biology: problems and solutions.

Fitzpatrick ER.

Seton Hall Law Rev. 2013 Nov 1;43(4):1363-402. No abstract available.

PMID:
24308082
7.

The scope of utility in the twenty-first century: new guidance for gene-related patents.

Summers TM.

Georgetown Law J. 2003 Jan;91(2):475-509. No abstract available.

PMID:
15046071
8.

A level playing field for intellectual property enforcement.

Carter S.

Med Device Technol. 2004 May;15(4):11.

PMID:
15303555
9.

Bioprospecting, genetic patenting and indigenous populations: challenges under a restructured information commons.

Faye DJ.

J World Intellect Prop. 2004 May;7(3):401-28. No abstract available.

PMID:
16755699
10.
11.

Patents, biotechnology, and hematologic pathology.

Kettelberger DM, Gambrell P, McClung G.

Hematol Pathol. 1992;6(2):99-104. Review. No abstract available.

PMID:
1607346
12.

Patenting genes? A finger in the dike of a bricks-and-mortar patent system.

White GB.

Am J Bioeth. 2002 Summer;2(3):20. No abstract available.

PMID:
12230846
13.

Creating value in a medical device company through intellectual assets.

Harrison RJ.

Conf Proc IEEE Eng Med Biol Soc. 2007;2007:4381-5. Review.

PMID:
18002975
14.

Patenting life.

O'Connor KW.

Cancer Invest. 1992;10(1):61-70. No abstract available.

PMID:
1735013
15.

Written description.

Becker DM.

Nat Rev Drug Discov. 2004 Oct;3(10):821. No abstract available.

PMID:
15497245
16.

Open source and biotech.

Bains W.

Nat Biotechnol. 2005 Sep;23(9):1046. No abstract available.

PMID:
16151387
17.

Second Basket's negative impact.

Carbon CC.

Science. 2008 Mar 14;319(5869):1483. doi: 10.1126/science.319.5869.1483c. No abstract available.

PMID:
18339920
18.

Patents versus settling for the soft option.

Carter S.

Med Device Technol. 2004 Mar;15(2):19. No abstract available.

PMID:
15154334
19.

Biotechnology patents: strategies for meeting economic and ethical concerns.

Gold ER.

Nat Genet. 2002 Apr;30(4):359. No abstract available.

PMID:
11925560
20.

Equivalents in biotechnology patents.

Auer HE.

Nat Biotechnol. 2003 Mar;21(3):329-31. No abstract available.

PMID:
12610574

Supplemental Content

Support Center